当前位置： 阿仪网 > 生物试剂/抗体/细胞 > 试剂盒 > 小鼠ELISA试剂盒 > 今品化学技术（上海）有限公司 > 产品展示 > ELISA检测试剂盒 > 小鼠ELISA检测试剂盒 > 小鼠组织型纤溶酶原激活剂(t-PA)ELISA试剂盒*新闻在线48T/96T
小鼠组织型纤溶酶原激活剂(t-PA)ELISA试剂盒*新闻在线48T/96T
价格：￥998
品牌名称：$brandModel.Title型号：48T/96T原产地：中国大陆 更新时间：2026/10/23 11:11:56
产品摘要：小鼠组织型纤溶酶原激活剂(t-PA)ELISA试剂盒*新闻在线为今品化学技术（上海）有限公司主打产品，质量好,发货及时,灵敏度高，特异性强，重复性好，其他动物类试剂盒种属一应俱全,指标数千种。公司配有专业实验室可寄样免费代检测支持现场观摩,提供售前售中售后全方位服务，欢迎来电询价或在线咨询索取产品说明书~
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：550
企业档案
会员类型：标准版
已获得阿仪网信誉 等级评定
20成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网标准版会员：9年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：3251677
详细内容
小鼠组织型纤溶酶原激活剂(t-PA)elisa试剂盒*新闻在线液体类标本：
包括血清、血浆、尿液、胸腹水、脑脊液、细胞培养上清等。
1）血清：
室温血液自然凝固10-20分钟后，离心20分钟左右（2000-3000转/分）。仔细收集上清。保存过程中如有沉淀形成，应再次离心。
2）血浆：
应根据标本的要求选择EDTA、柠檬酸钠或肝素作为抗凝剂，混合10-20分钟后，离心20分钟左右（2000-3000转/分）。仔细收集上清。保存过程中如有沉淀形成，应再次离心。
3）尿液：
用无菌管收集。离心20分钟左右（2000-3000转/分）。仔细收集上清。保存过程中如有沉淀形成，应再次离心。胸腹水、脑脊液参照此实行。
4）细胞培养上清：
A、检测分泌性的成份时，用无菌管收集。离心20分钟左右（2000-3000转/ 分）。仔细收集上清。
B、检测细胞内的成份时，用PBS（PH7.2⁻⁷.4）稀释细胞悬液，细胞浓度达到100万/ml左右。通过反复冻融，以使细胞破坏并放出细胞内成份。离心20分钟左右（2000-3000转/分）。仔细收集上清。保存过程中如有沉淀形成，应再次离心。
5）组织标本：
切割标本后，称取重量。加入一定量的PBS，PH7.4。用液氮迅速冷冻保存备用。标本融化后仍然保持2-8℃的温度。加入一定量的 PBS（PH7.4），用手工或匀浆器将标本匀浆充分。离心20分钟左右（2000-3000转/分）。仔细收集上清。分装后一份待检测，其余冷冻备用
小鼠组织型纤溶酶原激活剂(t-PA)ELISA试剂盒*新闻在线用途：本产品仅供科学研究
规格：48T/96T(凡购买本公司试剂盒提供免费代测服务)
Elisa试剂盒报价，Elisa试剂盒价格，Elisa试剂盒说明书，Elisa试剂盒技术，Elisa试剂盒售后，Elisa试剂盒代测详情咨询
试剂盒性能:
1．准确性：标准品线性回归与预期浓度相关系数R值，大于等于0.9900。
2．灵敏度：最低检测浓度小于10 pg/ml。
3．特异性：不与其它可溶性结构类似物交叉反应。
4．重复性：板内、板间变异系数均小于15%。
贮藏：2-8℃，避光防潮保存。
有效期：6个月
”注意事项：
1．请每次测定的同时做标准曲线，最好做复孔。如标本中待测物质含量过高(样本OD值大于标准品孔第一孔的OD值)，请先用样品稀释液稀释一定倍数(n倍)后再测定，计算时请最后乘以总稀释倍数(×n×5)。
2．封板膜只限一次性使用，以避免交叉污染。
3．底物请避光保存。
4．严格按照说明书的操作进行，试验结果判定必须以酶标仪读数为准
公司提供ELISA试剂盒达6000多个品种，并且通过与科研部门的合作，不断增加产品资源，扩大本身的产品储备。从而有效解决了广大客户寻找产品难的问题, 与科研部门及各大专院校、制药企业建立了良好的合作关系
标本包括：血清、血浆、细胞上清液、尿液、体液、灌洗液、脑脊髓、心房水、胸房水、组织等等
种属包括：人、大鼠、小鼠、豚鼠、仓鼠、裸鼠、兔子、猪、犬、猴、马、牛、羊、鸡、鸭、鱼等等
小鼠组织型纤溶酶原激活剂(t-PA)ELISA试剂盒*新闻在线其他相关产品发布：
| 100μg/100μl | EphA2 Antibody | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | FAK Antibody | Human | WB,,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | ZAP70 Antibody | 70kDa | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | LAL Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | GLP Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | FGF2 Antibody | Human | WB, IHC ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | NPT Antibody | Human | WB , ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | HPRT Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000,, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | LSD1/AOF2 Antibody | 93kDa | Human; Mouse; Monkey | WB, IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | Calcyclin Antibody | Human | WB, IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | EphA1 Antibody | 108kDa | Human | WB, IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | cTnI Antibody | Human | WB, IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Mouse TUG Antibody | Mouse | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | ER-alpha Antibody | Human | WB, IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Rab25 Antibody | Human; Mouse | WB, IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Foxp3 Antibody | Human; Mouse | WB, IHC,IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Polyclonal KSHV ORF8 Antibody | Human | WB,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB. 1/500 - 1/2000 ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Antibody Pair to APOA5 Antibody | Human | WB, IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Ractopamine Antibody | N/A | ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | KSHV ORF26 Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000 ,ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | GAPDH Antibody | 37kDa | Human | WB, IHC,IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, IF.1/200 - 1/1000,ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | GST Antibody | N/A | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | RB Antibody | Human | IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | CHK1 Antibody | 56kDa | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | BSA Antibody | Bovine | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | CD19 Antibody | Human | WB, IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | MCL-1 Antibody | 37kDa | Human | WB, IHC,IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | Clenbuterol Antibody | N/A | ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | MSH2 Antibody | 105kDa | Human; Monkey | WB, IHC,IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | CD3 Antibody | Human | IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC. 1/200 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | CD10 Antibody | Human | IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC. 1/200 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | IL-6 Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB. 1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | CD14 Antibody | Human | IHC,IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC.1/200 - 1/1000,IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | SARS-M Antibody | Human coronavirus | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | SARS-E2 Antibody | Human coronavirus | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | KSHV ORF45 Antibody | KSHV | WB, IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | KSHV K8a Antibody | Human | WB,IF, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000,IF.1/200 - 1/1000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | MCP-1 Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | IL-8 Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | IL-16 Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | Stathmin 1 (Phospho-Ser37) Antibody | P16949 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 | Integrin β3 (Phospho-Tyr773) Antibody E011060-1 50μg/50μl IHC, WB Human, Mouse Rabbit Paxillin (Phospho-Tyr31) Antibody E011201-1 50μg/50μl WB Human Rabbit FAK (Phospho-Tyr861) Antibody E011059-1 50μg/50μl WB Human, Mouse, Rat Rabbit Src(Phospho-Tyr418) Antibody E011091-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Stathmin 1 (Phospho-Ser37) Antibody E011225-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. Integrin alpha-V/beta-3 is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi＇s sarcoma lesions. Integrins are ubiquitously expressed adhesion molecules. They are cell-surface receptors that exist as heterodimers of alpha and beta subunits. At physiological conditions, integrins are highly glycosylated and contain a Ca2+ or Mg2+ ion, which is essential for ligand binding. Integrin receptors are critical for cell attachment to the extracellular matrix (ECM) and this is mediated through integrin-fibronectin, -vitronectin, -collagen and -laminin interactions. Intracellularly, integrins form adhesion complexes with proteins including talin, vinculin, paxillin and alpha-actinin. They also regulate kinases, such as focal adhesion kinase and Src family kinases, to mediate attachment to the actin cytoskeleton. Integrins also have a significant role in cell signaling and can activate protein kinases involved in the regulation of cell growth, division, survival, differentiation, migration and apoptosis. Glycoprotein II/IIIb (alphaIIbbeta3) is an integrin receptor found on the surface of platelets. It is involved in the cross-linking of platelets with fibrin, and so has a vital role in blood clot formation. Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). Phosphorylated on tyrosine residues during integrin-mediated cell adhesion, embryonic development, fibroblast transformation and following stimulation of cells by mitogens. PTK2 gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. At least four transcript variants encoding four different isoforms have been found for this gene, but the full-length natures of only two of them have been determined. Non-receptor protein-tyrosine kinase implicated in signaling pathways involved in cell motility, proliferation and apoptosis. Activated by tyrosine-phosphorylation in response to either integrin clustering induced by cell adhesion or antibody cross-linking, or via G-protein coupled receptor (GPCR) occupancy by ligands such as bombesin or lysophosphatidic acid, or via LDL receptor occupancy. Plays a potential role in oncogenic transformations resulting in increased kinase activity. Focal adhesion kinase (FAK), a non-receptor tyrosine kinase, is the first intracellular step in the signal transduction cascade initiated by the attachment of an integrin to the extracellular matrix at points known as focal adhesions. Therefore, FAK is plays a key role in cellular migration and motility. FAK has 3 functional domains: a focal adhesion targeting domain (FAT), a catalytic domain and a FERM domain, which mediates interactions with the cytoplasmic domains of integrins and growth factor receptors. FAK has multiple phosphorylation sites that are required for binding to adaptor proteins containing SH2 domains (e.g. Src and SH3 domains (e.g. CAS, GRAF)). Key amongst these phosphorylation s | ||
| 100μg/100μl | PGR Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | SOX2 Antibody | 34.3kDa | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.ELISA: Propose dilution 1/10000. | ||
| 100μg/100μl | NCOR1 Antibody | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.IHC:1/200 - 1/1000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | CD33 Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | MAP4K4 Antibody | Human | WB，ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | ALCAM Antibody | Human | IHC，ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC:1/200 - 1/1000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | SND1 Antibody | 102kDa | Human | WB ，ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.ELISA: Propose dilution 1/10000. | ||
| GABPA Antibody | 51kDa | Human; Mouse | WB ,IF,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.IF:1/200 - 1/1000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | Glucose-6-phosphate isomerase Antibody | 63kDa | Human | WB, IHC,IF,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.IHC: 1/200 - 1/1000.IF:1/200 - 1/1000. ELISA: Propose dilution 1/10000. | ||
| 100μg/100μl | FBLN5 Antibody | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.IHC: 1/200 - 1/1000. ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | EphB3 Antibody | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000.IHC: 1/200 - 1/1000. ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | cAMP Antibody | ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | ELISA: Propose dilution 1/10000. | ||||
| 100μg/100μl | Influenza B virus Nucleoprotein Antibody | Stain:B/Lee/40 | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB: 1/500 - 1/2000.ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | CD20 Antibody | Human | IHC ,IF,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC:1/200 - 1/1000,IF: 1/200 - 1/1000,ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | BNP Antibody | Human | IHC ,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | IHC:1/200 - 1/1000, ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | DDR2 Antibody | Human | WB, IHC,IF,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000,IHC:1/200 - 1/1000,IF:1/200 - 1/1000, ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | Cytokeratin 5 Antibody | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000 ,IHC:1/200 - 1/1000,ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | TIP60 Antibody | 60KDa | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000 ,IHC.1/200 - 1/1000,ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | MYST1 Antibody | 53Kd | Human | WB, IHC,IF,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000 ,IHC.1/200 - 1/1000,IF.1/200 - 1/1000,ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | IGF1R Antibody | Human | WB, IHC,ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000 ,IHC .1/200 - 1/1000,ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | GSK3 alpha Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000 ,ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | APP Antibody | Human | WB, IHC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB:1/500 - 1/2000, IHC:1/200 - 1/1000, ELISA: Propose dilution 1/10000. | |||
| 100μg/100μl | IL-10 Antibody | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA.Propose dilution 1/10000. | ||||
| 100μg/100μl | IL-1a Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | IFN-gamma Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA.Propose dilution 1/10000. | |||
| 100μg/100μl | CD8 Antibody | Human | FC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | FC: 1/200 - 1/400 , ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | CD4 Antibody | Human | FC, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | FC:1/200 - 1/400 ELISA.Propose dilution 1/10000. | |||
| 100μg/100μl | Apoa5(ab) Antibody | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000 ELISA.Propose dilution 1/10000. | |||
| 100μg/100μl | Apoa5(bd) Antibody | Human | ELISA. Propose dilution 1/10000. Not yet tested in other applications. Determining optimal working dilutions by titration test. | ELISA.Propose dilution 1/10000. | |||
| 100μg/100μl | human IgM Antibody | Human | ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | ELISA. Propose dilution 1/10000. | |||
| 100μg/100μl | BCL-10 Antibody | 26kDa | Human; Mouse | WB, IHC,IF, FCM, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, IF.1/200 - 1/1000, FCM.1/200 - 1/400 ELISA. Propose dilution 1/10000. | ||
| 100μg/100μl | human IgG Antibody | 50kDa | Human | WB, ELISA. Not yet tested in other applications. Determining optimal working dilutions by titration test. | WB.1/500 - 1/2000, ELISA.Propose dilution 1/10000. | ||
| 100μg/100μl | Nucleophosmin Antibody | 33kDa | Human; Monkey | WB, IHC, IF, ELISA. Not yet tested in other applications. | WB.1/500 - 1/2000, IHC.1/200 - 1/1000, IF.1/200 - 1/1000, ELISA.Propose dilution 1/10000. | ||
| 100μg/100μl | NMDAR1 (Phospho-Ser897) Antibody | Q05586 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 | |||
| 100μg/100μl | IRS-1 (Phospho-Ser612) Antibody | P35569 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | IKK-a/b (Phospho-Ser176) Antibody | O15111/ O14920 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | IKKa/b (Phospho-Ser180/181) Antibody | O15111/ O14920 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | IGF1R (Phospho-Tyr980) Antibody | P08069 | Human, Mouse, Rat | IHC: 1:50~1:100 | |||
| 100μg/100μl | HDAC1 (Phospho-Ser421/423) Antibody | Q13547 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Gab1 (Phospho-Tyr659) Antibody | Q13480 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Fyn (Phospho-Tyr530) Antibody | P06241 | Human, Mouse, Rat | IHC: 1:50~1:100 | |||
| 100μg/100μl | FLT3 (Phospho-Tyr591) Antibody | P36888 | Human | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | FGFR1 (Phospho-Tyr154) Antibody | P11362 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | CrkL (Phospho-Try207) Antibody | P46109 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Crk2 (Phospho-Try221) Antibody | Q64010 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | CHK2 (Phospho-Thr387) Antibody | O96017 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | CHK1 (Phospho-Ser317) Antibody | O14757 | Human, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | ASK1 (Phospho-Ser966) Antibody | Q99683 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | ASK1 (Phospho-Ser83) Antibody | Q99683 | Human | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | beta Amyloid A4 (Phospho-Thr743/668) Antibody | P05067 | Human, Mouse | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | ALK (Phospho-Tyr1586) Antibody | Q9UM73 | Human | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Abl1 (Phospho-Tyr204) Antibody | P00519 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Tsc2 (Phospho-Thr1462) Antibody | P49815 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Tsc2 (Phospho-Ser939) Antibody | P49815 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | Tsc2 (Phospho-Ser1254) Antibody | P49815 | Human | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | LKB1 (Phospho-Ser428) Antibody | Q15831 | Human, mouse, rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | LKB1 (Phospho-Ser334) Antibody | Q15831 | Human, Mouse | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | PDGF Receptor beta (Phospho-Tyr751) Antibody | P09619 | Human, Mouse, Rat | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | P53 (Phospho-Ser37) Antibody | P04637 | Human | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 | |||
| 100μg/100μl | P53 (Phospho-Ser20) Antibody | P04637 | Human, Mouse | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:4000 |
热门标签：小鼠组织型纤溶酶原激活剂,t-PA,ELISA,小鼠组织型纤溶酶原激活剂试剂盒
